Re-assess is not selling after holding a stock which has commercialised for over 5 years. Are you going to extend this to 2030 lol. And don't use the pandemic as an excuse again, PCK commercialised 18 months before COVID-19 happened in Singapore/NZ/UK and the uptake here was non existence until the government grant which allowed for their most growth actually occur during the pandemic.
I still recall those 100%+ numbers in their quarterly that you guys were ramping during this time and I told you it looked impressive as these are from a low base and guess what, the uptake here has slowdown and non existence since the government grant ended just like when they didn't have the government grant........
Ann: PainChek UK partnership with Nourish Care, page-9
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PCK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.4¢ |
Change
-0.002(5.56%) |
Mkt cap ! $55.61M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 3.7¢ | 3.4¢ | $45.39K | 1.278M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 497311 | 3.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.5¢ | 254838 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| PCK (ASX) Chart |